Llwytho...
Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations
Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment since their introduction ∼15 years ago. However, these monoclonal antibodies are associated with immune-related adverse events that can also affect the kidney, resulting in acute kidney injury (AKI), which is most commonly due...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Clin Kidney J |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8087122/ https://ncbi.nlm.nih.gov/pubmed/33970161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ckj/sfab052 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|